DUBLIN--(BUSINESS WIRE)--The "U.S. Pharmacy Benefit Management (PBM) Market Analysis Report By Business Model (Standalone, Health Insurance Providers, Retail Pharmacy), By End Use (Commercial, Federal), And Segment Forecasts, 2019 - 2026" report has been added to ResearchAndMarkets.com's offering.
The U.S. pharmacy benefits management market size is projected to reach USD 744.6 billion by 2026, exhibiting a CAGR of 9.2% during the forecast period. Increasing vertical integration of key market players, rising prevalence of chronic disease, and shrinking FDA generic-approval backlog are some of the primary growth stimulants for the market.
Vertical integration of pharmacy benefits management (PBM) organizations with health insurance companies are poised to result in increased control of PBMs over distribution systems. This will lead to rise in rebates, ultimately increasing the cost of drug list prices. Moreover, it will result in a monopoly of certain market player, concentrating sales and revenue generation.
The business of insuring and administering employee benefit programs in the country, especially, health care programs, is heavily regulated by federal and state laws and administrative agencies, such as the Department of Health and Human Services (HHS), State Departments of Insurance, Centers for Medicare & Medicaid Services (CMS), Internal Revenue Services, and Departments of Labor.
All PBM businesses in the U.S. must include home delivery and specialty pharmacies licensed as pharmacies in the states of establishment. Several states in the country regulate the scope of prescription (Rx) drug coverage and delivery channels to receive drugs for managed care organizations (MCOs), insurers, and Medicaid care plans. Certain home delivery and specialty pharmacies must be registered with the U.S. Drug Enforcement Administration (DEA) and individual state controlled substance authorities.
Further key findings from the study suggest:
- Based on business model, the market has been segmented into standalone PBM, health insurance providers, and retail pharmacy. Of these, PBMs associated with health insurers are likely to witness the fastest growth over the forecast period
- Rise in mergers and partnerships between market players is expected to result in an increased demand for PBM systems
- OptumRx and Express Scripts (merged with Cigna in December 2018) are among the key players merged or acquired by large health insurance providers
- Based on end use, the market has been divided into commercial and federal. Commercial PBM systems dominated the market and are estimated to maintain their dominance through 2026 owing to a large number of covered patients
- CVS Health; Aetna; Express Scripts; Cigna; OptumRx, Inc.; Walgreens Booth Alliance; MedImpact Healthcare Systems, Inc.; Anthem; and Rite Aid are some of the key players in the market.
Key Topics Covered
Chapter 1 Methodology & Scope
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 User Perspective Analysis
3.2.1 Consumer Behavior Analysis
3.2.2 Market Influencer Analysis
3.3 Market Dynamics
3.3.1 Market Driver Analysis
18.104.22.168 Vertical Integration Of Key Market Players
22.214.171.124 Introduction Of Improved Health Benefit Plans
126.96.36.199 Growing Prevalence Of Chronic Diseases In The U.S.
3.3.2 Market Restraint Analysis
188.8.131.52 Stringent regulations to cut back rebates
3.4 Penetration & Growth Prospect Mapping
3.4.1 Penetration & Growth Prospect Mapping Analysis
3.5 Business Environment Analysis Tools
3.5.1 Porter's Five Forces Analysis
184.108.40.206 Bargaining power of buyers: High
220.127.116.11 Bargaining power of suppliers: Moderate
18.104.22.168 Competitive rivalry: High
22.214.171.124 Threat of new entrants: Low
126.96.36.199 Threat of substitutes: High
3.5.2 Pestel Analysis
188.8.131.52 Political & Legal Landscape
184.108.40.206 Economic Landscape
220.127.116.11 Social Landscape
18.104.22.168 Technological Landscape
22.214.171.124 Environmental Landscape
3.6 Supply Chain Analysis
3.7 Regulatory Framework
Chapter 4 U.S. Pharmacy Benefits Management Market: Business Model Analysis
4.1 U.S. Pharmacy Benefits Management Business Model Market Share Analysis, 2018 & 2026
4.2 U.S. Pharmacy Benefits Management Business Model Market: Segment Dashboard:
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Business Model Segment
4.3.1 Standalone PBM
126.96.36.199 Standalone PBM Market, 2015 - 2026 (USD Billion)
4.3.2 Health Insurance Providers
188.8.131.52 Health Insurance Providers Market, 2015 - 2026 (USD Billion)
4.3.3 Retail Pharmacy
184.108.40.206 Retail Pharmacy Market, 2015 - 2026 (USD Billion)
Chapter 5 U.S. Pharmacy Benefits Management Market: End Use Analysis
5.1 U.S. Pharmacy Benefits Management End Use Market Share Analysis, 2018 & 2026
5.2 U.S. Pharmacy Benefits Management End Use Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the End Use
220.127.116.11 Commercial PBM market, 2015 - 2026 (USD Billion)
18.104.22.168 Federal PBM market, 2015 - 2026 (USD Billion)
Chapter 6 Competitive Analysis
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
6.3 Vendor Landscape
6.3.1 List Of Key Distributors And Channel Partners
6.3.2 Strategy Mapping
6.3.3 Major Deals & Strategic Alliances Analysis
6.4 U.S. Pharmacy Benefits Management (PBM) Market: Market Position Analysis (Based on Regional Presence and Recent Updates)
6.5 Company Profiles
- CVS Health
- Express Scripts Holding Company
- Optumrx Inc.
- Walgreens Boots Alliance Inc.
- Medimpact Healthcare Systems Inc.
- Rite Aid
For more information about this report visit https://www.researchandmarkets.com/r/61saur